Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.
De With RR, Rienstra M, Smit MD, Weijs B, Zwartkruis VW, Hobbelt AH, Alings M, Tijssen JGP, Brügemann J, Geelhoed B, Hillege HL, Tukkie R, Hemels ME, Tieleman RG, Ranchor AV, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC. De With RR, et al. Among authors: hobbelt ah. Europace. 2019 Apr 1;21(4):563-571. doi: 10.1093/europace/euy311. Europace. 2019. PMID: 30629160 Clinical Trial.
Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
Al-Jazairi MIH, Nguyen BO, De With RR, Smit MD, Weijs B, Hobbelt AH, Alings M, Tijssen JGP, Geelhoed B, Hillege HL, Tieleman RG, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC, Blaauw Y, Rienstra M; RACE 3 Investigators. Al-Jazairi MIH, et al. Among authors: hobbelt ah. Europace. 2021 Sep 8;23(9):1359-1368. doi: 10.1093/europace/euab062. Europace. 2021. PMID: 33899093 Free PMC article. Clinical Trial.
Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial.
Nguyen BO, Crijns HJGM, Tijssen JGP, Geelhoed B, Hobbelt AH, Hemels MEW, Mol WJM, Weijs B, Alings M, Smit MD, Tieleman RG, Tukkie R, Van Veldhuisen DJ, Van Gelder IC, Rienstra M; RACE 3 Investigators. Nguyen BO, et al. Among authors: hobbelt ah. Europace. 2022 Jul 15;24(6):910-920. doi: 10.1093/europace/euab270. Europace. 2022. PMID: 34791160 Free PMC article. Clinical Trial.
Rate control in atrial fibrillation: many questions still unanswered.
Van Gelder IC, Hobbelt AH, Mulder BA, Rienstra M. Van Gelder IC, et al. Among authors: hobbelt ah. Circulation. 2015 Oct 27;132(17):1597-9. doi: 10.1161/CIRCULATIONAHA.115.018952. Epub 2015 Sep 17. Circulation. 2015. PMID: 26384161 No abstract available.
Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.
Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brügemann J, Geelhoed B, Tieleman RG, Hillege HL, Tukkie R, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC; RACE 3 Investigators. Rienstra M, et al. Among authors: hobbelt ah. Eur Heart J. 2018 Aug 21;39(32):2987-2996. doi: 10.1093/eurheartj/ehx739. Eur Heart J. 2018. PMID: 29401239 Clinical Trial.
15 results